Similar articles

• The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).

  Moake JL. Moake JL. Prog Clin Biol Res. 1990;337:135-40. Prog Clin Biol Res. 1990. PMID: 2191307 Review. No abstract available.
• von Willebrand factor in thrombotic thrombocytopenic purpura.

  Furlan M, Lämmle B. Furlan M, et al. Thromb Haemost. 1999 Aug;82(2):592-600. Thromb Haemost. 1999. PMID: 10605756 Review. No abstract available.
• [Treatment of the hemolytic-uremic syndrome and thrombotic thrombopenic purpura].

  Villegas A, Alvarez-Sala JL, Espinós D. Villegas A, et al. Sangre (Barc). 1983;28(5):635-41. Sangre (Barc). 1983. PMID: 6364423 Review. Spanish. No abstract available.
• von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  Moake JL, McPherson PD. Moake JL, et al. Transfus Med Rev. 1990 Apr;4(2):163-8. doi: 10.1016/s0887-7963(90)70261-1. Transfus Med Rev. 1990. PMID: 2134624 Review. No abstract available.
• Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome.

  Laurence J, Mitra D. Laurence J, et al. Semin Hematol. 1997 Apr;34(2):98-105. Semin Hematol. 1997. PMID: 9109211 Review. No abstract available.